Navigation Links
AAIPharma Services Corp. Names Patrick Walsh Chief Executive Officer
Date:9/14/2010

WILMINGTON, N.C., Sept. 14 /PRNewswire/ -- AAIPharma Services Corp., a leading provider of pharmaceutical product development services for more than 30 years, announced today that it has appointed Patrick D. Walsh to chief executive officer.  Water Street, a strategic private equity firm focused exclusively on health care that acquired AAIPharma Services in a divestiture transaction from its parent company in 2009, was instrumental in recruiting Mr. Walsh to the position.  

Mr. Walsh, who has nearly 30 years of pharmaceutical manufacturing experience, will focus on advancing AAIPharma's next phase of strategic growth following its establishment as a standalone company.  Mr. Walsh has served in executive roles at multiple pharmaceutical companies, including as president and CEO of Kadmus Pharmaceuticals, Inc., and president and COO of Gensia Sicor.  He also served as CEO of a specialty diagnostic company, and led the U.S. and international business groups for Fujisawa USA.  Most recently, Mr. Walsh founded a management consulting firm that assisted companies with achieving key corporate objectives in the pharmaceutical, contract manufacturing and biotechnology industries.

"Pat has an impressive record of consistently leading pharmaceutical businesses to achieve high levels of growth over the course of his career.  He is the ideal executive to advance AAIPharma Services forward, as we focus on pursuing growth opportunities through a combination of organic initiatives and strategic acquisitions.  Pat's core skills of business development, relationship-building, and sales and marketing will contribute significantly to AAIPharma and our goal of building it into the leading provider of pharmaceutical development services," said Pete Strothman, a principal with Water Street and a member of AAIPharma Services' board of directors.

In addition to his executive experience, Mr. Walsh has served on the boards of directors of more than 10 companies in the pharmaceutical and contract manufacturing industries.  L. Lee Karras, who led AAIPharma Services through its transition to an independent company, will continue in his role as president and will also assume the responsibility of chief operating officer.  He will work closely with Mr. Walsh to implement the company's strategic growth plan.

"AAIPharma Services is highly regarded for its expertise and ability to collaborate with its customers to consistently deliver high-quality results.  It is this unique value proposition, which the company has honed over the past 30 years that will serve as the foundation for our future," said Mr. Walsh.  "I look forward to working with the team to determine how we can best build on the company's core capabilities to provide even greater value to our customers and expand our presence on a much greater scale globally."

About AAIPharma Services Corporation

AAIPharma Services Corp. is a leading provider of services that encompass the entire process of pharmaceutical drug development from discovery through commercialization. The company specializes in analytical chemistry, formulation development, clinical packaging, oral drug delivery and contract manufacturing. AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies throughout North America.  It is headquartered in Wilmington, North Carolina.  For more information on the company, visit www.aaipharma.com.

About Water Street Healthcare Partners

Water Street Healthcare Partners is a strategic private equity firm focused exclusively on health care.  The firm has a strong record of building market-leading companies across key growth sectors in health care.  It has partnered with some of the world's leading health care companies on its investments including: Johnson & Johnson, Medtronic and Smith & Nephew.  Water Street's team is comprised of industry executives and private equity professionals with decades of experience investing in and operating global health care businesses.  The firm is headquartered in Chicago.  For more information about Water Street, visit www.wshp.com.


'/>"/>
SOURCE AAIPharma Services Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. West Pharmaceutical Services, Inc. Appoints New Director
2. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
3. U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter
4. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
5. AcroMetrix Renews Contract With Group Services for Americas Blood Centers
6. amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
7. Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment
8. Supportive Oncology Services Accrues One Million Cancer Patient Self-Reported Assessments
9. Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials
10. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
11. Qualia Clinical Services Chooses ALPHADAS(R) for Phase I Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... and CAMBRIDGE, Massachusetts , July 25, 2017 ... repurposing drugs to treat rare nervous system diseases, has concluded ... develop and market the drug SOM0226 against transthyretin amyloidosis (ATTR). ... very promising results in a Phase 2 study conducted in ... office in the United States ...
(Date:7/24/2017)... July 24, 2017 IBM (NYSE: IBM ) ... Quadrant for Solid-State Arrays (SSA) for the fourth year in ... According to Gartner, "Vendors in the Leaders quadrant have the ... Vision. A vendor in the Leaders quadrant has the market ... the acceptance of new technologies. These vendors demonstrate a clear ...
(Date:7/21/2017)... EDMONTON, Alberta , July 21, 2017 /PRNewswire/ ... University of Alberta in Edmonton, Canada ... partner journal, Schizophrenia 1 , demonstrating that AI ... schizophrenia with 74% accuracy. This retrospective analysis also ... symptoms in schizophrenia patients with significant correlation, based ...
Breaking Medicine Technology:
(Date:7/25/2017)... OK (PRWEB) , ... July 25, 2017 , ... ... proud to announce the launch of their partnership to provide the Pharmacist ... the first pharmacy-focused platform in the country with the ability to develop the ...
(Date:7/25/2017)... ... July 25, 2017 , ... Therachat ... will be exhibiting and providing demos of its smart journaling platform at the ... Center in Washington D.C. from August 3-6, 2017. , The APA Annual Convention ...
(Date:7/25/2017)... , ... July 25, 2017 , ... ... ATM provider in the United States, today announced its partnership with financial technology ... , The foundation of the solution lies within Hyosung’s superior ATMs, assisted ...
(Date:7/25/2017)... Jacksonville, Fla. (PRWEB) , ... July 25, 2017 , ... ... employee and father Ezra Clark is taking advantage of a new benefit for employees ... “It really means a lot that the company supports me and other employees as ...
(Date:7/25/2017)... TX (PRWEB) , ... July 25, 2017 , ... SignatureCare ... emergencies in the Austin, TX area 24 Hours a day. , The ... Austin, TX. , “We’ve been open four months now and things are running ...
Breaking Medicine News(10 mins):